Concise review: cancer cells escape from oncogene addiction: understanding the mechanisms behind treatment failure

Francesca Pellicano1, Leena Mukherjee, Tessa L Holyoake

  • 1Paul O'Gorman Leukaemia Research Centre, Institute of Cancer Sciences, College of Medical, Veterinary & Life Sciences, University of Glasgow, Glasgow, United Kingdom.

Stem Cells (Dayton, Ohio)
|February 13, 2014
PubMed

Insights

Cancer cells often depend on specific oncogenes for survival, but stem cells may evade this addiction. This can lead to treatment failure, particularly in chronic myeloid leukemia (CML).

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Stem Cell Research

Background:

  • Oncogene addiction is a key concept in cancer therapy, where tumors depend on specific oncogenes.
  • Targeting these oncogenes can induce significant tumor regression.
  • However, resistance mechanisms, especially in cancer stem cells, can limit long-term treatment efficacy.

Purpose of the Study:

  • To review the evidence for oncogene addiction in solid tumors.
  • To explore potential escape mechanisms from oncogene addiction.
  • To specifically focus on the role of chronic myeloid leukemia (CML) stem cells in treatment failure.

Main Methods:

  • Literature review of studies on oncogene addiction in various cancers.
  • Analysis of proposed mechanisms for treatment resistance.
  • Case study focus on chronic myeloid leukemia (CML) and its stem cell population.

Main Results:

  • Oncogene addiction is observed in several solid tumors, with varying degrees of dependence.
  • Cancer stem cells may not be addicted to the driving oncogene, contributing to relapse.
  • Mechanisms of resistance include quiescent stem cells, high oncoprotein levels, and acquired mutations.

Conclusions:

  • Oncogene addiction is a critical vulnerability in many cancers, but not universally applicable to cancer stem cells.
  • Understanding escape mechanisms is crucial for developing more effective therapies, especially for CML.
  • Targeting cancer stem cells and their unique biology is essential for durable cancer remission.

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
2.6K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

3.8K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.0K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

1.4K
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

1.1K